Indication

Chronic heart failure following myocardial infarction

Chronic heart failure following myocardial infarction is a progressive cardiovascular syndrome characterized by the persistent inability of the heart to maintain adequate systemic perfusion. Read more about Chronic heart failure following myocardial infarction

35 drugs 32 manufacturers

Advertisement

Drugs that treat it

Common Chronic heart failure following myocardial infarction therapies.

Showing 10–18 of 35 drugs

RAMIPRIL

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+4
BLUEPOINT LABOR

EPLERENONE

HYPERTENSION·+1
Upsher-Smith Laboratories

RAMIPRIL

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+4
RISING PHARM

EPLERENONE

DIURETICS·HYPERTENSION·+1
ACCORD HEALTHCA
Filter & compare in the drug finder →Opens the drug finder with Chronic heart failure following myocardial infarction preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic heart failure following myocardial infarction.

Chronic heart failure following myocardial infarction is a progressive cardiovascular syndrome characterized by the persistent inability of the heart to maintain adequate systemic perfusion.

Affecting patients with prior ischemic myocardial injury, it develops primarily due to irreversible cardiomyocyte loss, infarct scar formation, and adverse ventricular remodeling that precipitates left ventricular systolic or combined dysfunction.

Pathophysiologically, ongoing neurohormonal activation—including the renin-angiotensin-aldosterone and sympathetic nervous systems—drives progressive ventricular dilation, chamber wall thinning, and myocardial fibrosis.

Clinically, affected individuals experience chronic exertional dyspnea, fatigue, reduced exercise tolerance, and signs of systemic or pulmonary venous congestion.

Personalize your experience

Follow Chronic heart failure following myocardial infarction and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it